Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tonga Healthcare Daily.
Press releases published on August 13, 2025
Biofrontera Inc. Reports Second Quarter 2025 Financial Results and Provides a Business Update
GlobeNewswire
·
August 13, 2025
Woburn, MA, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ:BFRI) (the "Company"), a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy in dermatology, today reported financial results for the …
BioSig Technologies Inc. Announces Proposed Public Offering
GlobeNewswire
·
August 13, 2025
Los Angeles, CA, Aug. 13, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (“BioSig” or the “Company”) which recently merged with Streamex Exchange Corporation (“Streamex”) (NASDAQ: BSGM) today announced its intention to offer shares of common stock (or …
Applied Therapeutics Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 13, 2025
- CMT-SORD program advances; meeting scheduled with the FDA in Q3 2025 to discuss govorestat for the treatment of CMT-SORD - Presented full 12-month clinical results and new topline data from INSPIRE Phase 2/3 trial of govorestat for the treatment of CMT- …
Precipio Announces its Q2-2025 Financial Results
GlobeNewswire
·
August 13, 2025
NEW HAVEN, Conn., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), filed its 10-Q report today. The following are the highlights of the Company’s financial performance and outlook for 2025. “Yet another …
PharmaCorp Rx Inc. Announces New Credit Facilities With CIBC and Unveils Pharmacist Co-Ownership Financing Initiative
GlobeNewswire
·
August 13, 2025
SASKATOON, Saskatchewan, Aug. 13, 2025 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) is pleased to announce that it has entered into a credit agreement with Canadian Imperial Bank of Commerce (“CIBC”) providing the …
LAVA Reports Second Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
August 13, 2025
Announced entry into an agreement to be acquired by XOMA Royalty Corporation for between $1.16 and $1.24 per share in cash, plus a contingent value right related to LAVA’s two partnered assets and unpartnered programs Consummation of acquisition expected …
Corza Medical ouvre un laboratoire d’innovation pour les textiles biomédicaux afin d’accélérer le développement de produits FEO
GlobeNewswire
·
August 13, 2025
TAUNTON, Royaume-Uni, 13 août 2025 (GLOBE NEWSWIRE) -- Corza Medical, l’un des principaux fabricants mondiaux de technologies chirurgicales et de composants de dispositifs médicaux, a annoncé aujourd’hui l’ouverture de son laboratoire d’innovation pour les …
Corza Medical eröffnet Innovationslabor für biomedizinische Textilien zur Beschleunigung der OEM-Produktentwicklung
GlobeNewswire
·
August 13, 2025
TAUNTON, Großbritannien, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Corza Medical, ein weltweit führender Hersteller chirurgischer Technologien und Komponenten für medizinische Geräte, hat heute die Eröffnung seines Innovationslabors für biomedizinische Textilien …
rYojbaba Co., Ltd. Announces Pricing of $5 Million Initial Public Offering of Japanese Common Shares and Listing on Nasdaq
GlobeNewswire
·
August 13, 2025
FUKUOKA, Japan, Aug. 13, 2025 (GLOBE NEWSWIRE) -- rYojbaba Co., Ltd. (“rYojbaba” or the “Company”), a Japanese labor consulting and health services company, today announced the pricing of its initial public offering of 1,250,000 Japanese common shares at …
2025 Winners of the 31st-Annual Eric Dostie Memorial College Scholarship Announced
GlobeNewswire
·
August 13, 2025
TEMECULA, Calif., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Nufactor®, a specialty infusion company and subsidiary of FFF Enterprises, Inc., is pleased to announce the names of its 2025 Eric Dostie Memorial College Scholarship recipients. The annual scholarship …
SCYNEXIS Reports Second Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
August 13, 2025
First new patient dosed in Phase 3 MARIO study following the lifting of the FDA clinical hold, triggering a $10M milestone payment from GSK. An additional $20M milestone will be triggered upon the six month anniversary of the new patient dosing; as …
Onco360 adds Modeyso™ (dordaviprone) to portfolio of Oncology and Rare Cancer therapies as a National Specialty Pharmacy Provider
GlobeNewswire
·
August 13, 2025
LOUISVILLE, Ky., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected as a pharmacy partner by Jazz Pharmaceuticals for Modeyso™ (dordaviprone). It is indicated for the treatment of adult and …
Aptose Reports Second Quarter 2025 Results
GlobeNewswire
·
August 13, 2025
Tuspetinib Continues to Demonstrate Excellent Safety and Complete Responses in the TUSCANY Clinical Trial of Tuspetinib in AML Triple Drug Frontline Therapy at 120 mg Dose Cohort Safety Review Committee (CSRC) Recommends Tuspetinib Dose Escalation to 160 …
Opus Genetics Announces Financial Results for Second Quarter 2025 and Provides Corporate Update
GlobeNewswire
·
August 13, 2025
- Positive 12-month Phase 1/2 clinical data in adult cohort and early pediatric clinical data support potential for meaningful vision restoration with OPGx-LCA5 - - FDA grants Regenerative Medicine Advanced Therapy (RMAT) designation for OPGx-LCA5 - - …
Vivani Medical Provides Business Update Including $10M Equity Financing and Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 13, 2025
Company plans rapid advancement of semaglutide implant NPM-139, following positive weight loss data from an ongoing preclinical study of NPM-139 and promising results from the LIBERATE-1 Phase 1 clinical study of NPM-115 New $10M equity financing to enable …
Alvotech Reports Results for the First Six Months of 2025 and Provides a Business Update
GlobeNewswire
·
August 13, 2025
Strong performance driven by over 200% growth in product revenues year-on-year Best quarter in Alvotech’s history in terms of operating cash flows Continued expansion of commercial partnerships for pipeline assets Alvotech listed on Nasdaq Stockholm Market …
Acrivon Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights
GlobeNewswire
·
August 13, 2025
Continued advancement of two clinical-stage assets, both with clinically demonstrated single-agent anti-tumor activity -- ACR-368 in a registrational-intent Phase 2 study in endometrial cancer and ACR-2316 in a Phase 1 study in AP3-predicted tumor types …
KBR Awarded an Estimated $2.459 Billion Contract to Support Astronaut Health and Performance for Space Missions
GlobeNewswire
·
August 13, 2025
HOUSTON, Aug. 13, 2025 (GLOBE NEWSWIRE) -- KBR (NYSE: KBR) announced today it has been awarded an estimated $2.459 billion NASA contract to support astronaut health, occupational health, and research that could help mitigate health risks for future human …
60 Degrees Pharmaceuticals Announces Second Quarter 2025 Results
GlobeNewswire
·
August 13, 2025
A now resolved supply disruption led to Q2 net product revenue decline but higher profitability due to increased usage of a cash-pay distribution model $1.97 million cash on hand, runway through March 31, 2026 WASHINGTON, Aug. 13, 2025 (GLOBE NEWSWIRE) -- …
Aardvark Therapeutics Reports Second Quarter 2025 Financial Results and Provides Pipeline and Business Updates
GlobeNewswire
·
August 13, 2025
Compelling new ARD-201 preclinical data informs optimized Phase 2 clinical development strategy of obesity programs: Phase 2 POWER trial of oral ARD-201 to focus on weight rebound in patients discontinuing GLP-1RA therapy, while Phase 2 STRENGTH trial to …